{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:06:13Z","timestamp":1780581973556,"version":"3.54.1"},"reference-count":25,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"5","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Lung cancer remains the leading cause of cancer-related mortality worldwide. Immune checkpoint inhibitors (ICIs) targeting the PD-1\/PD-L1 pathway have significantly improved survival outcomes in non\u2013small cell lung cancer (NSCLC), and treatment selection is influenced by the degree of PD-L1 expression. Although ICI use began in 2017, there is a lack of data on PD-L1 expression in NSCLC among Jordanian patients. This study aimed to estimate the prevalence of PD-L1 expression and its association with demographic, clinical, and molecular characteristics, including EGFR mutation and ALK rearrangements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This retrospective observational study reviewed electronic medical records for all patients with lung cancer diagnosed at King Hussein Cancer Center from January 1, 2017, to April 1, 2024. Included patients had histologically confirmed NSCLC and were tested for PD-L1 expression. PD-L1 expression was considered positive if the tumor proportion score (TPS) was \u22651%. Descriptive statistics were performed to summarize patient characteristics. Comparisons between TPS 1%-49% and TPS \u226550% groups were performed using chi-square tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Of the 1,872 screened patients, 1,508 met the inclusion criteria and were included in the analysis. In this sample, the majority of patients were male (79%), former smokers (70%), presented with advanced disease (stage III\/IV, 86%), and had adenocarcinoma histology (71%). Approximately 25% presented with squamous cell carcinoma. The prevalence of PD-L1 positivity was 68% (n = 1,022). Among the PD-L1\u2013positive patients, 59% had TPS 1%-49% and 41% had TPS \u226550%. Among patients tested for EGFR mutation and ALK fusion, alterations were identified in 16.6% and 8.4% of tested patients, respectively. In PD-L1\u2013positive tumors, EGFR wild-type status was significantly associated with high PD-L1 expression (TPS \u226550%) compared with EGFR-mutated tumors (56%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      44%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This first comprehensive analysis of PD-L1 prevalence in patients with NSCLC in Jordan demonstrates a relatively high prevalence of both PD-L1 positivity (\u22651%) and high expression (\u226550%) compared with reported data from other regions. Distinct molecular associations were observed, with higher PD-L1 expression in ALK-rearranged and EGFR wild-type tumors. These findings underscore the need for prospective and multicenter studies to further identify the biologic and clinical implications of PD-L1 expression in Jordanian patients with NSCLC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-26-00114","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:59:08Z","timestamp":1780084748000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of PD-L1 Expression in Non\u2013Small Cell Lung Cancer: A Real-World Analysis From Jordan"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-7708","authenticated-orcid":true,"given":"Osama","family":"El Khatib","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-6872","authenticated-orcid":true,"given":"Nour","family":"Obeidat","sequence":"additional","affiliation":[{"name":"Cancer Control Office, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8661-9006","authenticated-orcid":true,"given":"Abeer","family":"Yaseen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2573-6741","authenticated-orcid":true,"given":"Rnad","family":"Khader","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram","family":"Al-Yagoub","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Haroon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"},{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Zayed","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9771-2687","authenticated-orcid":true,"given":"Majed","family":"Ghlailat","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4719-3933","authenticated-orcid":true,"given":"Yazan","family":"Hamadneh","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4615-7372","authenticated-orcid":true,"given":"Laith","family":"AL-Showbaki","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Haddad","sequence":"additional","affiliation":[{"name":"Pathology Department, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Yaser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"},{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5951-7356","authenticated-orcid":true,"given":"Naser","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-6148","authenticated-orcid":true,"given":"Riad","family":"Abdel Jalil","sequence":"additional","affiliation":[{"name":"Department of Surgery, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"AL-Batsh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2959-1177","authenticated-orcid":true,"given":"Zaid","family":"Abdel Rahman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-1976","authenticated-orcid":true,"given":"Omar","family":"Shahin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"},{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-0694","authenticated-orcid":true,"given":"Mohammad","family":"Ma'koseh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"},{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1161-9138","authenticated-orcid":true,"given":"Khalid","family":"Halahleh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-4716","authenticated-orcid":true,"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4832-2960","authenticated-orcid":true,"given":"Mohammed J.","family":"Al-Jaghbeer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6772-9363","authenticated-orcid":true,"given":"Majdi Hasan","family":"Aljadayeh","sequence":"additional","affiliation":[{"name":"Medical Oncology, Hematology &amp; Stem Cell Transplant Department, Royal Medical Services, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Al Maani","sequence":"additional","affiliation":[{"name":"Oncology and Radiology Hospital, Al Bashir Hospitals, Ministry of Health, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-6618","authenticated-orcid":true,"given":"Faris","family":"Tamimi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7492-6374","authenticated-orcid":true,"given":"Kamal","family":"Al-rabi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan"},{"name":"School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_5_3_2","unstructured":"Ministry of Health Non-Communicable Diseases Directorate: Jordan Cancer Registry: Cancer Incidence in Jordan 2022. Amman Jordan Ministry of Health Hashemite Kingdom of Jordan"},{"key":"e_1_3_5_4_2","volume-title":"WHO Global Report on Trends in Prevalence of Tobacco Use 2000\u20132030","author":"WHO","year":"2024","unstructured":"WHO: WHO Global Report on Trends in Prevalence of Tobacco Use 2000\u20132030. Geneva, Switzerland: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/www.who.int\/publications\/i\/item\/9789240039322"},{"key":"e_1_3_5_5_2","volume-title":"GLOBOCAN 2022: Jordan","author":"International Agency for Research on Cancer","year":"2024","unstructured":"International Agency for Research on Cancer: GLOBOCAN 2022: Jordan. Lyon, France, IARC, 2024"},{"key":"e_1_3_5_6_2","unstructured":"Global Cancer Observatory: Cancer tomorrow: Future cancer burden projections for Jordan (Trachea bronchus and lung cancer; population 400). Lyon France IARC. Globocan 2022"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad7118"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0456-5"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"e_1_3_5_11_2","first-page":"1103","article-title":"PD-L1 expression as a predictive biomarker in NSCLC: A meta-analysis","volume":"12","author":"Aguiar PN","year":"2017","unstructured":"Aguiar PN Jr, De Mello RA, Hall P, et al: PD-L1 expression as a predictive biomarker in NSCLC: A meta-analysis. J Thorac Oncol 12:1103-1112, 2017","journal-title":"J Thorac Oncol"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.06.012"},{"key":"e_1_3_5_13_2","first-page":"100188","article-title":"Prevalence of programmed death ligand-1 expression in patients diagnosed with non-small cell lung cancer in Lebanon","volume":"24","author":"Fakhri G","year":"2020","unstructured":"Fakhri G, Abou Alaiwi S, Mukherji D, et al: Prevalence of programmed death ligand-1 expression in patients diagnosed with non-small cell lung cancer in Lebanon. Cancer Treat Res Commun 24:100188, 2020","journal-title":"Cancer Treat Res Commun"},{"key":"e_1_3_5_14_2","first-page":"80","article-title":"Expression of immune response markers in Arab patients with lung cancer","volume":"13","author":"Jazieh AR","year":"2018","unstructured":"Jazieh AR, Al Sudairy R, Abu-Shawer O, et al: Expression of immune response markers in Arab patients with lung cancer. Ann Thorac Med 13:80-86, 2018","journal-title":"Ann Thorac Med"},{"key":"e_1_3_5_15_2","volume-title":"Jordan National Stepwise Survey (STEPs) for Noncommunicable Diseases Risk Factors, Jordan 2019","unstructured":"Jordan National Stepwise Survey (STEPs) for Noncommunicable Diseases Risk Factors, Jordan 2019. https:\/\/www.moh.gov.jo\/Echobusv3.0\/SystemAssets\/5f91caaf-c257-4806-837c-b1028147b692.pdf"},{"key":"e_1_3_5_16_2","volume-title":"Cigarette Smoking in Jordan: Prevalence, Manufacturing, Demand, and Taxation","author":"Khader Y","year":"2023","unstructured":"Khader Y: Cigarette Smoking in Jordan: Prevalence, Manufacturing, Demand, and Taxation. JUST, 2023. https:\/\/tobacconomics.org\/research\/cigarette-smoking-in-jordan-prevalence-manufacturing-demand-and-taxation\/"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2024.25.8.2841"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-022-00121-8"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-023-00167-2"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2024.2738"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2023.08.008"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-018-0469-6"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.100868"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12539-019-00331-0"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.04.008"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-26-00114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:26:53Z","timestamp":1780579613000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-26-00114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1200\/GO-26-00114"],"URL":"https:\/\/doi.org\/10.1200\/go-26-00114","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2026-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2600114"}}